Background
Methods
Ethical considerations
Study participants
Clinical assessment
-
Mild or no visual impairment: presenting distance visual acuity equal to or better than 6/18
-
Moderate visual impairment: presenting distance visual acuity worse than 6/18 but equal to or better than 6/60
-
Severe visual impairment: presenting distance visual acuity worse than 6/60 but equal to or better than 3/60
-
Blindness: presenting distance visual acuity worse than 3/60
-
Primary open angle glaucoma (POAG): optic nerve damage meeting any of the three categories of evidence above, in an eye which does not have evidence of angle closure on gonioscopy, and where there is no identifiable secondary cause.
-
Pseudoexfoliative glaucoma (XFG) is open angle glaucoma associated with characteristic pseudoexfoliative material deposited at the pupil margin or anterior surface of the lens; on gonioscopy there may be with hyperpigmention of the trabecular meshwork or exfoliative material in the angle.
-
Chronic angle closure glaucoma (CACG) is optic nerve damage meeting any of the three categories of evidence above, in an eye which have evidence of angle closure on gonioscopy, and where there is no identifiable secondary cause.
-
Early Glaucoma: Early glaucomatous disc features (e.g., VCDR 0.7) and (or) mild VF defect not within 10° of fixation (e.g., MD better than −6 dB on HVF 24–2)
-
Moderate Glaucoma: Moderate glaucomatous disc features (e.g., VCDR 0.75–0.85) and (or) moderate VF defect not within 10° of fixation (e.g., MD from −6 .to −12 dB on HVF 24–2)
-
Advanced Glaucoma: Advanced glaucomatous disc features (e.g. VCDR >0.9) and (or) VF defect within 10° of fixation (e.g., MD worse than −12 dB on HVF 24–2)
Structured interview
Data analysis
Results
Socio-demographic characteristics
Variable | Cases | Controls |
p-value* | ||
---|---|---|---|---|---|
n/307 | (%) | n/76 | (%) | ||
Sex | 0.87 | ||||
Male | 201 | (65.5) | 49 | (64.5) | |
Female | 106 | (34.5) | 27 | (35.5) | |
Age | 0.62 | ||||
18–30 | 7 | (2.3) | 2 | (2.6) | |
31–40 | 22 | (7.2) | 5 | (6.6) | |
41–50 | 33 | (10.7) | 8 | (10.5) | |
51–60 | 61 | (19.9) | 15 | (19.7) | |
61–70 | 110 | (35.8) | 28 | (36.8) | |
≥ 71 | 74 | (24.1) | 18 | (23.7) | |
Marital status | 0.06 | ||||
Married | 216 | (70.4) | 62 | (81.6) | |
Widowed | 40 | (13.0) | 10 | (13.2) | |
Divorced | 28 | (9.1) | 2 | (2.6) | |
Single | 23 | (7.5) | 2 | (2.6) | |
Ethnicity | 0.65 | ||||
Amhara | 298 | (97.1) | 73 | (96.1) | |
Tigre | 9 | (2.9) | 3 | (3.9) | |
Religion | 0.16 | ||||
Orthodox Christian | 283 | (92.2) | 64 | (84.2) | |
Muslim | 19 | (6.2) | 12 | (15.8) | |
Protestant | 5 | (1.6) | |||
Residence | 0.02 | ||||
Urban | 137 | (44.6) | 19 | (25.0) | |
Rural | 170 | (55.4) | 57 | (75.0) | |
Education | 0.20 | ||||
None | 138 | (45.0) | 42 | (53.3) | |
Informal (able to read and write) | 93 | (30.3) | 18 | (23.7) | |
Primary school | 29 | (9.4) | 7 | (9.2) | |
Secondary school and above | 47 | (15.3) | 9 | (11.8) | |
Occupation | 0.03 | ||||
Government employee | 56 | (18.2) | 15 | (19.7) | |
Farmer | 130 | (42.3) | 43 | (56.6) | |
House wife | 65 | (21.2) | 11 | (14.5) | |
Dependent on family | 56 | (18.2) | 7 | (9.2) | |
Monthly Income (Ethiopian Birr) | <0.0001 | ||||
< 400 | 119 | (48.5) | 10 | (13.2) | |
400–1000 | 110 | (35.8) | 42 | (55.3) | |
> 1000 | 48 | (15.6) | 24 | (31.6) |
Clinical characteristics
Variable | n/307 | (%) |
---|---|---|
Duration of diagnosis | ||
< 1 year | 75 | (24.4) |
1-5 Years | 194 | (63.2) |
≥ 6 years | 38 | (12.4) |
Duration of treatment | ||
< 1 year | 156 | (50.8) |
1–5 years | 130 | (42.3) |
≥ 6 years | 21 | (6.8) |
Presence of other ocular disease | ||
Yes | 149 | (48.5) |
No | 158 | (51.5) |
Visual Acuity (better eye) | ||
Normal | 111 | (36.2) |
Moderate visual impairment | 126 | (41.0) |
Severe visual impairment | 58 | (18.9) |
Blind | 12 | (3.9) |
Type of glaucoma | ||
Primary open angle glaucoma | 164 | (53.4) |
Pseudoexfoliation glaucoma | 111 | (36.2) |
Chronic angle closure glaucoma | 32 | (10.4) |
Stage of glaucoma | ||
Early | 126 | (41.0) |
Moderate | 68 | (22.1) |
Advanced | 113 | (36.8) |
Laterality | ||
Unilateral | 28 | (9.1) |
Bilateral | 279 | (90.9) |
Quality of life
Domain | Cases | Controls | Difference |
P value* | |||
---|---|---|---|---|---|---|---|
Mean | (95% CI) | Mean | (95% CI) | Mean | (95% CI) | ||
Central and Near vision | 6.1 | (3.5–8.7) | 3.3 | (2.5–4.1) | 2.8 | (2.5–3.1) | <0.0001 |
Outdoor mobility | 3.2 | (1.8–4.6) | 1.3 | (0.9 1.7) | 1.9 | (1.7–2.1) | <0.0001 |
Peripheral vision | 19.3 | (10.3–28.3) | 7.2 | (6.7–7.7) | 12.1 | (11.1–13.1) | <0.0001 |
Dark adaptation & Glare | 17.7 | (11.7–23.7) | 6.9 | (4.7–9.1) | 10.8 | (10.1–11.5) | <0.0001 |
Overall Score | 46.3 | (28.8–63.8) | 18.6 | (15.2–22.0) | 27.7 | (23.7–31.6) | <0.0001 |
Variable | Domain | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Central & near vision | Outdoor Mobility | Peripheral vision | Dark adaptation and glare | Overall score | ||||||
Mean | (95% CI) | Mean | (95% CI) | Mean | (95% CI) | Mean | (95% CI) | Mean | (95% CI) | |
Age (years) | ||||||||||
18–30 | 3.7 | (1.9–5.5) | 1.9) | (0.9–2.9 | 11.6 | (5.1–18.0) | 12.4 | (8.4–16.5) | 29.6 | (17.4–41.7) |
31–40 | 2.9 | (0.8–6.9) | 1.8 | (0.4–3.9) | 11.5 | (−2.2–25.5) | 11.7 | (3.0–20.4) | 28.2 | (2.1–54.3) |
41–50 | 5.9 | (2.2–9.7) | 2.9 | (0.8–5.0) | 18.6 | (5.0–32.1) | 14.4 | (6.0–23.0) | 41.9 | (16.3–67.4) |
51–60 | 5.8 | (2.1–9.4) | 3.0 | (0.9–5.0) | 18.7 | (5.4–32.0) | 16.5 | (8.2–24.9) | 44 | (18.9–68.9) |
61–70 | 4.8 | (2.9–10.2) | 3.6 | (1.6–5.6) | 21.0 | (7.9–34.1) | 19.2 | (11.1–27.5) | 50.4 | (25.7–75.0) |
> 70 | 6.8 | (3.2–10.5) | 3.6 | (1.6–5.7) | 20.7 | (7.5–33.9) | 19.9 | (11.7–28.3) | 51.1 | (26.2–75.9) |
P valuea
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
P valueb
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
Sex | ||||||||||
Male | 7.2 | (6.1–8.4) | 3.8 | (3.2–4.5) | 24.9 | (20.8–29.1) | 20.8 | (18.1–23.6) | 56.9 | (48.8–64.9) |
Female | 6.1 | (4.0–8.4) | 2.8 | (2.0–4.5) | 19.7 | (11.9–27.7) | 17.9 | (12.7–23.1) | 47.1 | (31.7–62.4) |
P valuea
| 0.02 | 0.03 | 0.02 | 0.03 | 0.01 | |||||
P valueb
| – | – | – | – | 0.06 | |||||
Residence | ||||||||||
Rural | 7.4 | (6.5–8.2) | 3.9 | (3.4–4.3) | 23.9 | (20.9–26.9) | 20.5 | (18.5–22.5) | 55.7 | (49.9–61.5) |
Urban | 6.4 | (4.9–7.8) | 3.4 | (2.5–4.1) | 20.6 | (15.2–25.5) | 18.3 | (14.8–21.7) | 48.4 | (38.3–58.5) |
P valuea
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
P valueb
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
Educational status | ||||||||||
Unable to write and read | 6.7 | (6.3–7.1) | 3.5 | (3.3–3.7) | 21.0 | (19.6–22.3) | 18.6 | (17.6–19.5) | 49.8 | (47.2–52.4) |
Only read and write | 6.8 | (5.8–7.7) | 3.6) | (3.1–4.1 | 22.5 | (19.0–25.9) | 19.5 | (17.0–21.8) | 52.4 | (45.7–59.0) |
Primary school (1–8) | 4.3 | (3.0–5.6) | 2.3 | (1.6–3.0) | 15.3 | (10.6–19.8) | 13.8 | (10.6–17.0) | 35.7 | (26.9–44.5) |
Secondary school (9–12) | 4.8 | (3.4–6.2) | 2.1 | (1.3–2.8) | 13.5 | (8.6–18.4) | 17.3 | (13.9–20.5) | 37.7 | (28.3–47.2) |
Certificate and above | 3.1 | (1.7–4.5) | 1.5 | (0.7–2.5) | 8.3 | (3.4–13.1) | 11.0 | (7.0–14.3) | 23.9 | (14.6–33.2) |
P valuea
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
P valueb
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
Monthly income (ETB) | ||||||||||
< 400 | 6.9 | (6.6–7.3) | 3.7 | (3.5–3.9) | 22.9 | (21.6–24.2) | 19.5 | (18.6–20.4) | 53.1 | (50.5–55.6) |
401–1000 | 5.6 | (4.8–6.6) | 3.1 | (2.6–3.6) | 18.3 | (15.0–21.6) | 16.7 | (14.4–19.0) | 43.8 | (37.3–50.2) |
> 1000 | 4.3 | (3.3–5.5) | 1.7 | (1.1–2.3) | 10.8 | (16.8–14.6) | 14.1 | (11.4–16.9) | 30.9 | (23.2–38.6) |
P valuea
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
P valueb
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Variable | Domain | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Central and near vision | Outdoor Mobility | Peripheral vision | Dark adaptation and glare | Overall score | ||||||
Mean | (95% CI) | Mean | (95% CI) | Mean | (95% CI) | Mean | (95% CI) | Mean | (95% CI) | |
Duration of diagnosis | ||||||||||
< 1 year | 4.9 | (4.3–5.4) | 2.7 | (2.3–3.0) | 16.2 | (14.2–18.2) | 14.7 | (13.4–16.0) | 38.5 | (34.6–42.3) |
1–5 years | 6.5 | (5.2–7.7) | 3.5 | (2.7–4.1) | 20.7 | (16.3–25.1) | 18.9 | (16.1–21.7) | 49.6 | (41.2–57.9) |
> 5 years | 6.5 | (4.9–8.0) | 3.1 | (2.1–3.9) | 16.3 | (12.9–23.8) | 17.0 | (13.5–20.6) | 35.0 | (34.4–55.4) |
P valueac
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
P valueb
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
Duration of treatment | ||||||||||
< 1 year | 6.0 | (5.6–6.4) | 3.0 | (2.8–3.2) | 18.7 | (17.2–20.1) | 16.8 | (15.9–17.7) | 44.5 | (41.8–47.3) |
1–5 years | 6.1 | (5.1–7.1) | 3.4 | (2.9–3.9) | 20.1 | (16.5–23.6) | 18.1 | (16.5–21.1) | 48.5 | (41.6–55.3) |
> 5 years | 6.5 | (5.0–8.1) | 3.0 | (2.1–3.8) | 19.9 | (14.3–25.3) | 16.6 | (13.1–20.3) | 46.1 | (35.3–56.8) |
P valuead
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
P valueb
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
Visual acuity | ||||||||||
Normal | 4.8 | (4.4–5.2) | 2.5 | (2.3–2.7) | 15.2 | (13.6–16.7) | 14.8 | (13.8–15.9) | 37.3 | (34.3–40.2) |
Moderate VI | 6.3 | (5.3–7.3) | 3.4 | (2.9–4.0) | 20.5 | (17.0–24.3) | 18.7 | (16.1–21.2) | 49.1 | (42.1–56.0) |
Severe VI | 7.4 | (6.3–8.6) | 3.7 | (3.0–4.3) | 21.7 | (17.6–25.9) | 19.6 | (16.8–22.5) | 52.5 | (44.5–60.4) |
Blind | 9.7 | (7.9–11.4) | 4.9 | (3.8–5.9) | 32.0 | (25.5–38.4) | 23.9 | (19.6–28.3) | 70.5 | (58.1–82.8) |
P valuea
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
P valueb
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
Glaucoma stage | ||||||||||
Early | 5.3 | (4.9–5.7) | 2.8 | (2.6–3.1) | 16.9 | (15.3–18.4) | 16.2 | (15.1–17.2) | 41.2 | (38.2–44.2) |
Moderate | 6.6 | (5.4–7.8) | 3.2 | (2.6–3.9) | 19.9 | (15.7–24.0) | 18.4 | (15.6–21.2) | 48.2 | (40.1–56.2) |
Advanced | 6.7 | (5.6–7.7) | 3.5 | (2.9–4.2) | 21.8 | (17.9–25.5) | 19.0 | (16.4–21.4) | 50.9 | (43.6–58.3) |
P valuea
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |||||
P valueb
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Domain | Cases with normal visual acuity (n = 111) | Controls (n = 76) | Mean difference |
P value*
| |||
---|---|---|---|---|---|---|---|
Mean | (95% CI) | Mean | (95% CI) | Mean | (95% CI) | ||
Central and Near vision domain | 4.8 | (4.4–5.2) | 3.3 | (2.5–4.1) | 1.5 | (0.9–2.1) | <0.0001 |
Outdoor mobility domain | 2.5 | (2.3–2.7) | 1.3 | (0.9–1.7) | 1.2 | (1.0–2.0) | <0.0001 |
Peripheral vision domain | 15.2 | (13.6–16.7) | 7.2 | (6.7–7.7) | 8.3 | (6.2–9.7) | <0.0001 |
Dark adaptation and Glare domain | 14.8 | (13.8–15.9) | 6.9 | (4.7–9.1) | 7.9 | (6.6–9.2) | <0.0001 |
Overall Score | 37.3 | (34.3–40.2) | 18.6 | (15.2–22.0) | 18.7 | (15.1–22.1) | <0.0001 |
Domain | Cases with Mild glaucoma (n = 126) | Controls (n = 76) | Mean difference |
P value*
| |||
---|---|---|---|---|---|---|---|
Mean | (95% CI) | Mean | (95% CI) | Mean | (95% CI) | ||
Central and Near vision domain | 5.3 | (4.9–5.7) | 3.3 | (2.5–4.1) | 2.0 | (1.5–2.6) | <0.0001 |
Outdoor mobility domain | 2.8 | (2.6–3.1) | 1.3 | (0.9–1.7) | 1.5) | (1.3–1.9 | <0.0001 |
Peripheral vision domain | 16.9 | (15.3–18.4) | 7.2 | (6.7–7.7) | 9.7 | (7.7–11.6) | <0.0001 |
Dark adaptation and Glare domain | 16.2 | (15.1–17.2) | 6.9 | (4.7–9.1) | 9.3 | (7.8–10.7) | <0.0001 |
Overall Score | 41.2 | (38.2–44.2) | 18.6 | (15.2–22.0) | 22.6 | (18.7–26.4) | <0.0001 |